Analysis of pancreatic cancer samples from public databases revealed that SUMO1/2 expression is inversely associated with the infiltration of various tumor-infiltrating immune cells, including activated B cells, memory B cells, and effector memory CD8 T cells. The gene discussed is CD8A; the disease is neoplasm.